Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FZL33
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,273
Award facts
- Contract value 100% obligated
- $10,273.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,273.32 to DMS Pharmaceutical Group Inc. for XOLAIR 150 mg/ml auto-injector, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was issued without a set-aside designation on September 26, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. The company specializes in distributing branded and generic pharmaceutical products, biologics, and medical consumables to federal healthcare systems, particularly military facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026 under the SPE2DB program. The IDC enables the agency to procure a comprehensive range of pharmaceutical items supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively while maintaining a robust portfolio of pharmaceutical product deliveries to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FZL33?
SPE2DB25FZL33 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FZL33 worth?
The government has obligated $10,273 on SPE2DB25FZL33.
Is contract SPE2DB25FZL33 an order under another contract?
Yes. SPE2DB25FZL33 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL33 competed?
The extent of competition for SPE2DB25FZL33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award